An outbreak of Galerina sulciceps -like (Galerina cf. sulciceps) mushroom poisoning.
Autor: | Cao M; Department of Nephrology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.; Sichuan Clinical Research Center for Nephrology, Luzhou, Sichuan, China.; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, Sichuan, China., Luo S; Department of Nephrology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.; Sichuan Clinical Research Center for Nephrology, Luzhou, Sichuan, China.; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, Sichuan, China.; Department of Nephrology, Meishan people's hospital, Meishan, Sichuan, China., Kang T; Department of Nephrology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.; Sichuan Clinical Research Center for Nephrology, Luzhou, Sichuan, China.; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, Sichuan, China., Ou S; Department of Nephrology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.; Sichuan Clinical Research Center for Nephrology, Luzhou, Sichuan, China.; Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, Sichuan, China. |
---|---|
Jazyk: | angličtina |
Zdroj: | Clinical toxicology (Philadelphia, Pa.) [Clin Toxicol (Phila)] 2024 Nov; Vol. 62 (11), pp. 707-713. Date of Electronic Publication: 2024 Sep 20. |
DOI: | 10.1080/15563650.2024.2402501 |
Abstrakt: | Objective: Amatoxin-containing mushroom poisoning is a significant threat to public health worldwide. We report a mass poisoning of Galerina sulciceps -like mushrooms (Galerina cf. sulciceps) in Luzhou, Sichuan Province, China, aiming to offer insights for future prevention and treatment strategies. Methods: We performed a retrospective survey of mass mushroom poisoning patients admitted to our hospital. The demographic data, clinical presentations, laboratory findings, therapeutic measures and prognostic information were collected and analyzed. We used the 2020 Chinese consensus on the clinical diagnosis and treatment of amatoxin-containing mushroom poisoning to assess the severity of poisoning. Mushrooms were examined through morphological analysis, molecular biology identification, and toxin detection. Results: Our patient cohort consisted of nine males and six females, with mean (±SD) age of 34.9 ± 13.0 years. Gastrointestinal symptoms were the first to manifest, with mean (±SD) latency period of 13.4 ± 3.9 h. The majority of patients (86.7%) experienced nausea, vomiting, and diarrhea. Liver dysfunction was noted in 66.7% of patients, and thrombocytopenia was present in 26.7% of patients. In terms of the severity of poisoning, there were 10 mild cases and five severe cases. The mushrooms were provisionally labeled as Galerina cf. sulciceps , containing the toxins α-amanitin, β-amanitin, and γ-amanitin. All patients eventually recovered. Discussion: We report what appears to be a new type of mushroom that is morphologically and phylogenetically similar to the known Galerina sulciceps , but further study is required to determine if it represents a distinct species. Conclusion: This poisoning event was caused by unintentional ingestion of Galerina cf. sulciceps , an amatoxin-containing mushroom. Early symptoms are primarily gastrointestinal, with acute liver damage and coagulopathy being the main toxic effects. Thrombocytopenia is also prominent, particularly in severe cases. Accurate assessment and prompt, individualized, and intensive treatment are crucial for managing patients with acute Galerina cf. sulciceps poisoning effectively. |
Databáze: | MEDLINE |
Externí odkaz: |